Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
NIKKEI 225
38,835.10
+599.03
(+1.57%)
HANG SENG
18,479.37
-98.93
(-0.53%)
CRUDE OIL
78.28
-0.20
(-0.25%)
GOLD FUTURES
2,321.80
-9.40
(-0.40%)
DOW
38,884.26
+31.99
(+0.08%)
Bitcoin GBP
50,344.22
-267.21
(-0.53%)
Money
The retirement income gap no-one is talking about
People are living longer than ever before and this can impact how you plan for retirement
PDS Biotechnology Corporation (PDSB)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.7750
+0.0450
(+1.21%)
At close: 04:00PM EDT
3.7500
-0.03
(-0.66%)
After hours:
04:39PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
27,763
27,763
29,431
11,255
7,924
Selling general and administrative
15,282
15,282
12,241
10,185
6,978
Total operating expenses
43,045
43,045
41,672
21,439
14,902
Operating income or loss
-43,045
-43,045
-41,672
-21,439
-14,902
Interest expense
4,206
4,206
1,317
0
0
Income before tax
-44,348
-44,348
-42,054
-21,435
-14,847
Income tax expense
-1,406
-1,406
-1,199
-4,516
0
Income from continuing operations
-42,942
-42,942
-40,855
-16,918
-14,847
Net income
-42,942
-42,942
-40,855
-16,918
-14,847
Net income available to common shareholders
-42,942
-42,942
-40,855
-16,918
-14,847
Basic EPS
-1.71
-1.39
-1.43
-0.66
-0.89
Diluted EPS
-1.71
-1.39
-1.43
-0.66
-0.89
Basic average shares
30,296
30,952
28,599
25,597
16,745
Diluted average shares
30,296
30,952
28,599
25,597
16,745
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.